Plant Dopamine Biosynthesis With TyDC and PPO Modules
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The biosynthetic pathway for dopamine in plants remains unclear, limiting understanding and bioengineering applications for human and animal health, despite dopamine's importance in neurotransmission, disease treatment, and plant growth.
Innovation Solution
Genetically modify plants or plant cells with heterologous tyrosine decarboxylases (TyDC) and polyphenol oxidases (PPO) to produce dopamine, using promoters for stable expression and integration into the plant genome, enabling production and purification of dopamine and derivatives.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If heterologous tyrosine decarboxylases (TyDC) and polyphenol oxidases (PPO) are introduced into plants, then dopamine production is enabled and plant stress resilience is improved, but the biosynthetic pathway complexity increases and genetic modification complexity is required
Solution Approach 1:
The patent divides the dopamine biosynthesis pathway into separate functional modules: TyDC for tyrosine decarboxylation and PPO for polyphenol oxidation. These segmented enzyme functions are introduced as distinct heterologous genes, allowing independent optimization and control of each step in the pathway while building complexity systematically.
Solution Approach 2:
The patent uses promoters as intermediary elements to control the expression of TyDC and PPO genes. These promoters act as mediators that regulate when and where the enzymes are produced, enabling precise control over dopamine synthesis without requiring complex regulatory networks to be built from scratch.
2Stability of the object's composition
If heterologous TyDC and PPO genes are integrated into the plant genome, then stable dopamine production is achieved, but genetic modification and integration complexity increases
Solution Approach 1:
The patent combines TyDC and PPO genes into a unified genetic construct that can be integrated together into the plant genome. This merging approach allows both enzymes to be co-expressed and regulated as a functional unit, achieving stable dopamine production while managing genetic modification complexity through a single integration event rather than multiple separate modifications.
3Quantity of substance
If dopamine is produced at high levels in plants, then human and animal health applications are enabled, but melanin and phenols production increases which may have unwanted effects
Solution Approach 1:
The patent optimizes parameters such as promoter strength, enzyme expression levels, and substrate availability to produce high dopamine concentrations while controlling the side reactions that lead to melanin and phenols formation. By carefully adjusting these parameters, the pathway favors dopamine production over unwanted byproducts.
Solution Approach 2:
The patent recognizes that PPO activity can lead to unwanted phenols and melanin, but converts this by carefully controlling PPO expression and substrate availability to ensure that the oxidation activity is directed toward beneficial dopamine production rather than harmful byproducts. The potential harm of PPO is transformed into a benefit through precise enzymatic control.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances plant stress resilience, produces high levels of dopamine for human and animal health applications, and facilitates the production of valuable compounds like morphine and polydopamine for biomaterials, while reducing melanin and phenols.
Implementation Method 1
heterologous tyrosine decarboxylases (TyDC)... capable of producing dopamine
Implementation Method 2
heterologous polyphenol oxidases (PPO)... produces dopamine and dopamine-derived compound
Data Source
AI summary
The present invention provides for a genetically modified plant or plant cell capable of producing dopamine or dopamine-derived compound, comprising one or more heterologous tyrosine decarboxylases (TyDC) or one or more heterologous polyphenol oxidases (PPO).